2025 LaMontagne Lecture with Julie Gerberding

Dr. Julie Gerberding will be the keynote speaker at the 2025 John Ring LaMontagne Annual Keynote Lecture and Symposium. 

After the lecture will be a reception, followed by a special graduate student and postdoc career-oriented question and answer session with Dr. Gerberding.

The event is free, but seating is limited and must be reserved by March 24. The event will also be broadcast via livestream on the LCID website. 

Dr. Gerberding joined the FNIH as CEO in 2022. Previously she served as President of Merck Vaccines and as Executive Vice President and Chief Patient Officer at Merck & Co., Inc. In 2002 she became the first woman to head the U.S. Centers for Disease Control and Prevention (CDC), and during her tenure from 2002-2009, she responded to dozens of public health emergencies including avian influenza, SARS-CoV-1, food poisoning outbreaks and natural disasters. 

A world-renowned public health and biosecurity expert, Dr. Gerberding has received several awards, including the Department of Health and Human Services Distinguished Service Award and the United States Public Health Service Surgeon General’s Medallion. She has been included in Forbes Magazine’s 100 Most Powerful Women in the World and Time Magazine’s 100 Most Influential People in the World. She is deeply committed to ensuring that our expanding scientific capabilities are translated in sustainable improvements in health, well-being and biosecurity around the world.